How should meta-regression analyses be undertaken and interpreted?

Statistics in Medicine

Volumn 21, Issue 11, 2002, Pages 1559-1573

  Thompson, Simon G ^a   Higgins, Julian P T ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Ecological associations; False positive results; Heterogeneity; Meta analysis; Meta regression; Study level covariates

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DATA ANALYSIS; HUMAN; MEDICAL RESEARCH; META ANALYSIS; METHODOLOGY; PUBLICATION; RANDOMIZATION; REGRESSION ANALYSIS; RELIABILITY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BACTERIAL INFECTIONS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; HUMANS; META-ANALYSIS; MYOCARDIAL INFARCTION; STATISTICS;

EID: 0037098178     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1187     Document Type: Article

References (41)

1. Why sources of heterogeneity in meta-analysis should be investigated
2. A new perspective
3. Benefits of heterogeneity in meta-analysis of data from epidemiologic studies
4. Meta-analysis: Beyond the grand mean?
5. Summing up evidence: One answer is not always enough
6. A metaregression analysis of the dose-response effect of aspirin on stroke
7. Quantitative methods in the review of epidemiologic literature
8. A random effects regression model for meta-analysis
9. Explaining heterogeneity in meta-analysis: A comparison of methods
10. Advantages and limitations of meta-analytic regressions of clinical trial data
11. Exploring heterogeneity in randomised trials via meta-analysis
12. Statistical issues in a meta-regression analysis of randomized trials: Impact on the dietary sodium intake and blood pressure relationship
13. Detecting and describing heterogeneity in meta-analysis
14. Bayesian approaches to random effects meta-analysis: A comparative study
15. Reference Bayesian methods for generalized linear mixed models
16. Meta-analysis regression
17. Meta-analysis of continuous outcome data from individual patients
18. Meta-analysis for the evaluation of potential surrogate markers
19. Uses of ecological analysis in epidemiologic research
20. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis
21. The relation between treatment benefit and underlying risk in meta-analysis
22. Investigating underlying risk as a source of heterogeneity in meta-analysis
23. The population risk as an explanatory variable in research synthesis of clinical trials
24. Analysing the relationship between treatment effect and underlying risk in meta-analysis: Comparison and development of approaches
25. Statistical heterogeneity in systematic reviews of clinical trials: A critical appraisal of guidelines and practice
26. A consumer's guide to subgroup analysis
27. Subgroup analyses and other (mis)uses of baseline data in clinical trials
28. Controversies in meta-analysis: The case of the trials of serum cholesterol reduction
29. β blockade after myocardial infarction: Systematic review and meta-regression analysis
30. Single or multiple daily doses of aminoglycosides: A meta-analysis
31. Spurious precision? Meta-analysis of observational studies
32. Investigating and dealing with publication and other biases
33. Multilevel Statistical Models
34. Systematic reviews of trials and other studies
35. Why do we need systematic overviews of randomised trials?
36. A simulation study of the number of events per variable in logistic regression analysis
37. Diagnostic statistical procedures in medical meta-analyses
38. Bias in meta-analysis detected by a simple, graphical test